Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use
Relative Value Units (RVUs)
Calculator →
Clinical Information
When to Use
Pneumococcal conjugate vaccine, 13 valent
Common Scenarios
Documentation Requirements
- Vaccine product documented
- Patient response
Coding Guidelines
Common Modifiers
Bundling Rules
- Vaccine product code
- Bill separately from administration
Exclusions
- Do not bill with administration included
Coding Notes
Clinical scenarios
- Vaccine product documented
- Patient response
- Vaccine product documented
- Patient response
- Vaccine product documented
- Patient response
Who are you?
Code Details
Medicare Pricing
PFSRVU Breakdown
OPPS Details
Dosage: 0.5 ML
Payment Limit: $257.99
Automate Coding
Let OrbDoc AI automatically suggest codes from your clinical notes.
Patient? Check your bill.
Use our free analyzer to understand charges and spot errors.
Analyze My BillAsk OrbDoc AI
Get instant answers about 90670 - pricing, bundling rules, or billing questions.
Ask a QuestionFrequently Asked Questions
CPT 90670 is the billing code for "Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use". Pneumococcal conjugate vaccine, 13 valent
Key documentation requirements for CPT 90670 include: Vaccine product documented; Patient response. Missing or incomplete documentation is a leading cause of claim denials for this code.
Bundling considerations for CPT 90670: Vaccine product code. Bill separately from administration Use an NCCI bundling checker to verify specific code combinations before billing.
Common modifiers for CPT 90670 include: 59 (Distinct procedural service). Modifiers indicate special circumstances and can affect reimbursement or prevent claim denials.
The typical time requirement for CPT 90670 is Vaccine product code. Time-based codes require documentation of the actual time spent providing the service.